These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 186092)

  • 41. Fibrinogen and the early stages of polymerization to fibrin as studied by dynamic laser light scattering.
    Larsson U; Blombäck B; Rigler R
    Biochim Biophys Acta; 1987 Sep; 915(2):172-9. PubMed ID: 3651470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysfibrinogenemia in obstructive liver disease.
    Levy J; Pettei MJ; Weitz JI
    J Pediatr Gastroenterol Nutr; 1987; 6(6):967-70. PubMed ID: 3681583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the kinetics of the thrombin-controlled polymerization of fibrin.
    Visser A; Payens TA
    FEBS Lett; 1982 Jun; 142(1):35-8. PubMed ID: 7106285
    [No Abstract]   [Full Text] [Related]  

  • 45. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
    Cierniewski CS; Janiak A; Wyroba E
    Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombin clotting time and fibrin polymerization in liver cirrhosis.
    Szczepański M; Habior A; Szczepanik A; Soszka A; Grel K
    Mater Med Pol; 1994; 26(3):87-90. PubMed ID: 7603083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of calcium and synthetic peptides on fibrin polymerization.
    Furlan M; Rupp C; Beck EA; Svendsen L
    Thromb Haemost; 1982 Apr; 47(2):118-21. PubMed ID: 7101230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acquired dysfibrinogenemia in a child in the course of a liver disease].
    Maak B; Meyer M; Dietze H
    Monatsschr Kinderheilkd; 1990 Aug; 138(8):446-50. PubMed ID: 2215508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 51. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of plasma thrombomodulin (TM) levels in patients with liver disease].
    Akiyama K; Nakamura K; Makino I
    Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2559-67. PubMed ID: 1328724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Case of hypofibrinogenemia with disorders of fibrin polymerization during hepatic cirrhosis].
    Gouault-Heilmann M; Chardon E; Yvart J; Sultan C; Cattan D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():80-5. PubMed ID: 4620100
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
    Hofmann V; Gati WP; Straub PW
    Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance of the uranyl acetate test in the diagnosis of liver diseases].
    Fischer P; Reinelt D
    Z Gesamte Inn Med; 1968 Jun; 23(12):Suppl:177-9. PubMed ID: 5687435
    [No Abstract]   [Full Text] [Related]  

  • 56. Structure of fibrin and fibrinmonomer in renal and hepatic failure.
    Klingemann HG; Egbring R; Havemann K
    Klin Wochenschr; 1980 May; 58(10):533-5. PubMed ID: 7392532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The incipient stage in thrombin-induced fibrin polymerization detected by FCS at the single molecule level.
    Bark N; Földes-Papp Z; Rigler R
    Biochem Biophys Res Commun; 1999 Jun; 260(1):35-41. PubMed ID: 10381340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
    Connaghan DG; Francis CW; Ryan DH; Marder VJ
    Am J Clin Pathol; 1986 Sep; 86(3):304-10. PubMed ID: 3751995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma.
    Zhao X; Wang Z; Cao L; Zhang W; Bai X; Dong N; Yu Z; Ruan C
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):398-405. PubMed ID: 20410814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.